NCT01883323 2019-11-08Tumor-Infiltrating Lymphocytes And Low-Dose Interleukin-2 Therapy Following Cyclophosphamide And Fludarabine In Patients With MelanomaUniversity Health Network, TorontoPhase 2 Completed12 enrolled